Investment Professional

Ashley joined Investor Growth Capital’s New York office with the Healthcare team in 2003.  He focuses primarily on medical device and biopharmaceutical investments.

Prior to joining Investor Growth Capital, Ashley worked in the healthcare investment banking group at Lehman Brothers, where he completed various M&A, equity and debt transactions in the life science, specialty pharmaceutical and healthcare services sectors.

Ashley received his Bachelor of Science degree from Yale University in both Molecular Biology and Economics.

Ashley currently serves as a board member of Axiomed Spine Corporation and is a Board observer at Applied Spine Technologies, Biolex Therapeutics, Cayenne Medical and CHF Solutions.